A unique range of over 3000 novel substituted fluoro aromatic compounds functionalised with a variety of synthetically useful reactive groups.
US regulators will undertake a speedy review of Bristol-Myers Squibb’s application to expand use of its immunotherapy Opdivo to include...
Read More >
Recent launch of several new categories of compound which include the spirocyclic β-Lactams designed...
Read More >